Impurity exclusion and retention during crystallisation and recrystallisation. The phenacetin by ethylation of paracetamol process

Una cuestin̤ clave que enfrentan las industrias farmacǔticas y de qum̕ica fina es la generacin̤ de impurezas durante la qum̕ica del proceso y la retencin̤, o de otro modo, de štas durante la cristalizacin̤ y posterior procesamiento. Las directrices de la FDA reconocen las sustancias orgǹicas, los...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ētahi atu kaituhi:	Horgan Danielle E., Crowley Lorraine M., Stokes Stephen P., Lawrence Simon E., Moynihan Humphrey A., InTech
Hōputu:	Pukapuka
Reo:	Ingarihi
Ngā marau:	Industria farmacǔtica Qum̕ica inorgǹica Cristalizacin̤ Catalizadores Drug industry Chemistry inorganic Crystallization Catalysts sustancia farmacolg̤ica pharmacological substance
Urunga tuihono:	Impurity exclusion and retention during crystallisation and recrystallisation. The phenacetin by ethylation of paracetamol process
Tags:	Tāpirihia he Tūtohu No Tags, Be the first to tag this record!